Quantcast
Home > Quotes > PBE
x

Invesco Dynamic Biotech & Genome ETF (PBE) Quote & Summary Data

(ETF)
PBE 
$55.51
*  
2.18
4.09%
Get PBE Alerts
*Delayed - data as of Oct. 16, 2018  -  Find a broker to begin trading PBE now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks

Key Stock Data

Today's High / Low
$ 55.51 / $ 53.68
Share Volume
21,947
90 Day Avg. Daily Volume
141,680
Previous Close
$ 53.33
52 Week High / Low
$ 60.49 / $ 43.08
Market Cap
555,100,000
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0.02 %

Intraday Chart

News for PBE

Shares Traded

Share Volume:
21,947
90 Day Avg. Daily Volume:
141,680

Trading Range

The current last sale of $55.51 is 28.85% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 55.51 $ 60.49
 Low: $ 53.68 $ 43.08

Description

The PowerShares Dynamic Biotechnology and Genome Portfolio is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.


Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Management Fee 0.58
Asset Class equity
Leverage 1
Top Holdings
AMGN Amgen Inc 5.52%
PTCT PTC Therapeutics Inc 2.87%
HALO Halozyme Therapeutics Inc 2.86%
ALKS Alkermes PLC 2.77%
CSII Cardiovascular Systems Inc 2.75%
MYGN Myriad Genetics Inc 2.68%
IRWD Ironwood Pharmaceuticals Inc 2.66%
WVE WaVe Life Sciences Ltd 2.61%
EXEL Exelixis Inc 2.57%
ENTA Enanta Pharmaceuticals Inc 2.53%

Research Brokers before you trade

Want to trade FX?

Analyst Info